BioPharmX Corp·4

Jul 25, 7:16 PM ET

BioPharmX Corp 4

4 · BioPharmX Corp · Filed Jul 25, 2016

Insider Transaction Report

Form 4
Period: 2016-07-21
Transactions
  • Award

    Option to purchase common stock

    2016-07-21$0.62/sh+65,000$40,300175,000 total(indirect: By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03)
    Exercise: $0.62From: 2016-08-21Exp: 2026-07-21Common stock (65,000 underlying)
Footnotes (2)
  • [F1]This option vests ratably over 12 months with the first vesting starting on 8/21/16.
  • [F2]Mr. Morlock is a co-trustee and co-beneficiary of the Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT